Cargando…

Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells

Elevated levels of the pro-inflammatory cytokine tumor necrosis factor-α (TNFα) inhibit erythropoiesis and cause anemia in patients with cancer and chronic inflammatory diseases. TNFα is also a potent activator of the sphingomyelinase (SMase)/ceramide pathway leading to ceramide synthesis and regula...

Descripción completa

Detalles Bibliográficos
Autores principales: Orsini, Marion, Chateauvieux, Sébastien, Rhim, Jiyun, Gaigneaux, Anthoula, Cheillan, David, Christov, Christo, Dicato, Mario, Morceau, Franck, Diederich, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748125/
https://www.ncbi.nlm.nih.gov/pubmed/30546074
http://dx.doi.org/10.1038/s41418-018-0245-x
_version_ 1783452036482727936
author Orsini, Marion
Chateauvieux, Sébastien
Rhim, Jiyun
Gaigneaux, Anthoula
Cheillan, David
Christov, Christo
Dicato, Mario
Morceau, Franck
Diederich, Marc
author_facet Orsini, Marion
Chateauvieux, Sébastien
Rhim, Jiyun
Gaigneaux, Anthoula
Cheillan, David
Christov, Christo
Dicato, Mario
Morceau, Franck
Diederich, Marc
author_sort Orsini, Marion
collection PubMed
description Elevated levels of the pro-inflammatory cytokine tumor necrosis factor-α (TNFα) inhibit erythropoiesis and cause anemia in patients with cancer and chronic inflammatory diseases. TNFα is also a potent activator of the sphingomyelinase (SMase)/ceramide pathway leading to ceramide synthesis and regulating cell differentiation, proliferation, apoptosis, senescence, and autophagy. Here we evaluated the implication of the TNFα/SMase/ceramide pathway on inhibition of erythropoiesis in human CD34(+) hematopoietic stem/progenitor cells (CD34/HSPCs) from healthy donors. Exogenous synthetic C2- and C6-ceramide as well as bacterial SMase inhibited erythroid differentiation in erythropoietin-induced (Epo)CD34/HSPCs shown by the analysis of various erythroid markers. The neutral SMase inhibitor GW4869 as well as the genetic inhibition of nSMase with small interfering RNA (siRNA) against sphingomyelin phosphodiesterase 3 (SMPD3) prevented the inhibition by TNFα, but not the acid SMase inhibitor desipramine. Moreover, sphingosine-1-phosphate (S1P), a ceramide metabolite, restored erythroid differentiation, whereas TNFα inhibited sphingosine kinase-1, required for S1P synthesis. Analysis of cell morphology and colony formation demonstrated that erythropoiesis impairment was concomitant with a granulomonocytic differentiation in TNFα- and ceramide-treated EpoCD34/HSPCs. Inhibition of erythropoiesis and induction of granulomonocytic differentiation were correlated to modulation of hematopoietic transcription factors (TFs) GATA-1, GATA-2, and PU.1. Moreover, the expression of microRNAs (miR)-144/451, miR-146a, miR-155, and miR-223 was also modulated by TNFα and ceramide treatments, in line with cellular observations. Autophagy plays an essential role during erythropoiesis and our results demonstrate that the TNFα/neutral SMase/ceramide pathway inhibits autophagy in EpoCD34/HSPCs. TNFα- and ceramide-induced phosphorylation of mTOR(S2448) and ULK1(S758), inhibited Atg13(S355) phosphorylation, and blocked autophagosome formation as shown by transmission electron microscopy and GFP-LC3 punctae formation. Moreover, rapamycin prevented the inhibitory effect of TNFα and ceramides on erythropoiesis while inhibiting induction of myelopoiesis. In contrast, bafilomycin A1, but not siRNA against Atg5, induced myeloid differentiation, while both impaired erythropoiesis. We demonstrate here that the TNFα/neutral SMase/ceramide pathway inhibits erythropoiesis to induce myelopoiesis via modulation of a hematopoietic TF/miR network and inhibition of late steps of autophagy. Altogether, our results reveal an essential role of autophagy in erythroid vs. myeloid differentiation.
format Online
Article
Text
id pubmed-6748125
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-67481252019-09-18 Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells Orsini, Marion Chateauvieux, Sébastien Rhim, Jiyun Gaigneaux, Anthoula Cheillan, David Christov, Christo Dicato, Mario Morceau, Franck Diederich, Marc Cell Death Differ Article Elevated levels of the pro-inflammatory cytokine tumor necrosis factor-α (TNFα) inhibit erythropoiesis and cause anemia in patients with cancer and chronic inflammatory diseases. TNFα is also a potent activator of the sphingomyelinase (SMase)/ceramide pathway leading to ceramide synthesis and regulating cell differentiation, proliferation, apoptosis, senescence, and autophagy. Here we evaluated the implication of the TNFα/SMase/ceramide pathway on inhibition of erythropoiesis in human CD34(+) hematopoietic stem/progenitor cells (CD34/HSPCs) from healthy donors. Exogenous synthetic C2- and C6-ceramide as well as bacterial SMase inhibited erythroid differentiation in erythropoietin-induced (Epo)CD34/HSPCs shown by the analysis of various erythroid markers. The neutral SMase inhibitor GW4869 as well as the genetic inhibition of nSMase with small interfering RNA (siRNA) against sphingomyelin phosphodiesterase 3 (SMPD3) prevented the inhibition by TNFα, but not the acid SMase inhibitor desipramine. Moreover, sphingosine-1-phosphate (S1P), a ceramide metabolite, restored erythroid differentiation, whereas TNFα inhibited sphingosine kinase-1, required for S1P synthesis. Analysis of cell morphology and colony formation demonstrated that erythropoiesis impairment was concomitant with a granulomonocytic differentiation in TNFα- and ceramide-treated EpoCD34/HSPCs. Inhibition of erythropoiesis and induction of granulomonocytic differentiation were correlated to modulation of hematopoietic transcription factors (TFs) GATA-1, GATA-2, and PU.1. Moreover, the expression of microRNAs (miR)-144/451, miR-146a, miR-155, and miR-223 was also modulated by TNFα and ceramide treatments, in line with cellular observations. Autophagy plays an essential role during erythropoiesis and our results demonstrate that the TNFα/neutral SMase/ceramide pathway inhibits autophagy in EpoCD34/HSPCs. TNFα- and ceramide-induced phosphorylation of mTOR(S2448) and ULK1(S758), inhibited Atg13(S355) phosphorylation, and blocked autophagosome formation as shown by transmission electron microscopy and GFP-LC3 punctae formation. Moreover, rapamycin prevented the inhibitory effect of TNFα and ceramides on erythropoiesis while inhibiting induction of myelopoiesis. In contrast, bafilomycin A1, but not siRNA against Atg5, induced myeloid differentiation, while both impaired erythropoiesis. We demonstrate here that the TNFα/neutral SMase/ceramide pathway inhibits erythropoiesis to induce myelopoiesis via modulation of a hematopoietic TF/miR network and inhibition of late steps of autophagy. Altogether, our results reveal an essential role of autophagy in erythroid vs. myeloid differentiation. Nature Publishing Group UK 2018-12-13 2019-09 /pmc/articles/PMC6748125/ /pubmed/30546074 http://dx.doi.org/10.1038/s41418-018-0245-x Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Orsini, Marion
Chateauvieux, Sébastien
Rhim, Jiyun
Gaigneaux, Anthoula
Cheillan, David
Christov, Christo
Dicato, Mario
Morceau, Franck
Diederich, Marc
Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells
title Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells
title_full Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells
title_fullStr Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells
title_full_unstemmed Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells
title_short Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells
title_sort sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748125/
https://www.ncbi.nlm.nih.gov/pubmed/30546074
http://dx.doi.org/10.1038/s41418-018-0245-x
work_keys_str_mv AT orsinimarion sphingolipidmediatedinflammatorysignalingleadingtoautophagyinhibitionconvertserythropoiesistomyelopoiesisinhumanhematopoieticstemprogenitorcells
AT chateauvieuxsebastien sphingolipidmediatedinflammatorysignalingleadingtoautophagyinhibitionconvertserythropoiesistomyelopoiesisinhumanhematopoieticstemprogenitorcells
AT rhimjiyun sphingolipidmediatedinflammatorysignalingleadingtoautophagyinhibitionconvertserythropoiesistomyelopoiesisinhumanhematopoieticstemprogenitorcells
AT gaigneauxanthoula sphingolipidmediatedinflammatorysignalingleadingtoautophagyinhibitionconvertserythropoiesistomyelopoiesisinhumanhematopoieticstemprogenitorcells
AT cheillandavid sphingolipidmediatedinflammatorysignalingleadingtoautophagyinhibitionconvertserythropoiesistomyelopoiesisinhumanhematopoieticstemprogenitorcells
AT christovchristo sphingolipidmediatedinflammatorysignalingleadingtoautophagyinhibitionconvertserythropoiesistomyelopoiesisinhumanhematopoieticstemprogenitorcells
AT dicatomario sphingolipidmediatedinflammatorysignalingleadingtoautophagyinhibitionconvertserythropoiesistomyelopoiesisinhumanhematopoieticstemprogenitorcells
AT morceaufranck sphingolipidmediatedinflammatorysignalingleadingtoautophagyinhibitionconvertserythropoiesistomyelopoiesisinhumanhematopoieticstemprogenitorcells
AT diederichmarc sphingolipidmediatedinflammatorysignalingleadingtoautophagyinhibitionconvertserythropoiesistomyelopoiesisinhumanhematopoieticstemprogenitorcells